Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669596 | SCV000794365 | likely pathogenic | Carnitine palmitoyl transferase II deficiency, severe infantile form | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002531231 | SCV003330478 | pathogenic | Carnitine palmitoyltransferase II deficiency | 2022-03-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro211Valfs*24) in the CPT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CPT2 are known to be pathogenic (PMID: 16781677, 16996287). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 554042). This variant has not been reported in the literature in individuals affected with CPT2-related conditions. This variant is not present in population databases (gnomAD no frequency). |
Genome- |
RCV000669596 | SCV004179385 | likely pathogenic | Carnitine palmitoyl transferase II deficiency, severe infantile form | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004568527 | SCV005058525 | likely pathogenic | Encephalopathy, acute, infection-induced, susceptibility to, 4 | 2024-02-27 | criteria provided, single submitter | clinical testing |